EXACT Therapeutics AS

Director's Dealing • Nov 24, 2025

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Per Walday
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Exact Therapeutics AS
b)	LEI code	2138006ZE5JAL39AGD55
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument Identification code	Share options linked to the shares in Exact Therapeutics AS (ISIN: NO0010852213)
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0		0 610,643
d)	Aggregated information - Aggregated volume - Aggregated price	Sum 0 610,643 share options NOK 0		0 610,643
e)	Date of the transaction	2025-11-24
f)	Place of the transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Amir Snapir
2	Reason for the notification
a)	Position/status	CMO
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Exact Therapeutics AS
b)	LEI code		2138006ZE5JAL39AGD55
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument Identification code	Share options linked to the shares in Exact Therapeutics AS (ISIN: NO0010852213)
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0	120,000
		Sum 0	0	610,643
d)	Aggregated information - Aggregated volume - Aggregated price	120,000 share options NOK 0
e)	Date of the transaction	2025-11-24
f)	Place of the transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	John M. Edminson
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Exact Therapeutics AS
b)	LEI code		2138006ZE5JAL39AGD55
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument Identification code	Share options linked to the shares in Exact Therapeutics AS (ISIN: NO0010852213)
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Currency	Price(s)		Volume(s)
		NOK 0		0	60,000
		Sum 0		0	610,643
d)	Aggregated information - Aggregated volume - Aggregated price	60,000 share options NOK 0
e)	Date of the transaction	2025-11-24
f)	Place of the transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Caspar Foghsgaard
2	Reason for the notification
a)	Position/status	SVP Commercial & BD
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Exact Therapeutics AS
b)	LEI code		2138006ZE5JAL39AGD55
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument Identification code	Share options linked to the shares in Exact Therapeutics AS (ISIN: NO0010852213)
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Currency	Price(s)		Volume(s)
		NOK 0		0	60,000
		Sum 0		0	610,643
d)	Aggregated information - Aggregated volume - Aggregated price	60,000 share options NOK 0
e)	Date of the transaction	2025-11-24
f)	Place of the transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Svein Kvåle
2	Reason for the notification
a)	Position/status	COO
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Exact Therapeutics AS
b)	LEI code		2138006ZE5JAL39AGD55
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument Identification code	Share options linked to the shares in Exact Therapeutics AS (ISIN: NO0010852213)
b)	Nature of the transaction	Receipt of share options
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0	60,000
		Sum 0	0	610,643
d)	Aggregated information - Aggregated volume - Aggregated price	60,000 share options NOK 0
e)	Date of the transaction	2025-11-24
f)	Place of the transaction	XOFF – Outside a trading venue